FDA authorizes sale of first home COVID/flu combo test outside of emergency use The test joins other over-the-counter COVID-19/flu tests already available under emergency use authorization. CIDRAP

As the country heads into the respiratory illness season, the US Food and Drug Administration (FDA) announced yesterday its marketing authorization of the first over-the-counter (OTC) rapid-antigen COVID-19/flu combination test outside of emergency use authorization.